Literature DB >> 21960589

Developmental origins and impact of BCR-ABL1 fusion and IKZF1 deletions in monozygotic twins with Ph+ acute lymphoblastic leukemia.

Giovanni Cazzaniga1, Frederik W van Delft, Luca Lo Nigro, Anthony M Ford, Joannah Score, Ilaria Iacobucci, Elena Mirabile, Mary Taj, Susan M Colman, Andrea Biondi, Mel Greaves.   

Abstract

The timing and developmental sequence of events for BCR-ABL1(+) acute lymphoblastic leukemia (ALL), usually associated with IKAROS (IKZF1) deletions, are unknown. We assessed the status of BCR-ABL1 and IKZF1 genes in 2 pairs of monozygotic twins, one pair concordant, the other discordant for Philadelphia chromosome positive (Ph(+)) ALL. The twin pair concordant for ALL shared identical BCR-ABL1 genomic sequence indicative of monoclonal, in utero origin. One twin had IKZF1 deletion and died after transplantation. The other twin had hyperdiploidy, no IKZF1 deletion, and is still in remission 8 years after transplantation. In the twin pair discordant for ALL, neonatal blood spots from both twins harbored the same clonotypic BCR-ABL1 sequence. Low level BCR-ABL1(+) cells were present in the healthy co-twin but lacked the IKZF1 deletion present in the other twin's leukemic cells. The twin with ALL relapsed and died after transplantation. The co-twin remains healthy and leukemia free. These data show that in childhood Ph(+) ALL, BCR-ABL1 gene fusion can be a prenatal and possibly initiating genetic event. In the absence of additional, secondary changes, the leukemic clone remains clinically silent. IKZF1 is a secondary and probable postnatal mutation in these cases, and as a recurrent but alternative copy number change is associated with poor prognosis.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21960589      PMCID: PMC3217357          DOI: 10.1182/blood-2011-07-366542

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  30 in total

Review 1.  Origins of chromosome translocations in childhood leukaemia.

Authors:  Mel F Greaves; Joe Wiemels
Journal:  Nat Rev Cancer       Date:  2003-09       Impact factor: 60.716

Review 2.  Acute lymphoblastic leukemia.

Authors:  Ching-Hon Pui; Mary V Relling; James R Downing
Journal:  N Engl J Med       Date:  2004-04-08       Impact factor: 91.245

3.  Site-specific translocation and evidence of postnatal origin of the t(1;19) E2A-PBX1 fusion in childhood acute lymphoblastic leukemia.

Authors:  Joseph L Wiemels; Brian C Leonard; Yunxia Wang; Mark R Segal; Stephen P Hunger; Martyn T Smith; Vonda Crouse; Xiaomei Ma; Patricia A Buffler; Sharon R Pine
Journal:  Proc Natl Acad Sci U S A       Date:  2002-11-01       Impact factor: 11.205

4.  Leading prognostic relevance of the BCR-ABL translocation in adult acute B-lineage lymphoblastic leukemia: a prospective study of the German Multicenter Trial Group and confirmed polymerase chain reaction analysis.

Authors:  Beate Gleissner; Nicola Gökbuget; Claus R Bartram; Bart Janssen; Harald Rieder; Johannes W G Janssen; Christa Fonatsch; Axel Heyll; Dimitris Voliotis; Joachim Beck; Thomas Lipp; Gerd Munzert; Jürgen Maurer; Dieter Hoelzer; Eckhard Thiel
Journal:  Blood       Date:  2002-03-01       Impact factor: 22.113

Review 5.  Leukemia in twins: lessons in natural history.

Authors:  Mel F Greaves; Ana Teresa Maia; Joseph L Wiemels; Anthony M Ford
Journal:  Blood       Date:  2003-06-05       Impact factor: 22.113

Review 6.  Standardization and quality control studies of 'real-time' quantitative reverse transcriptase polymerase chain reaction of fusion gene transcripts for residual disease detection in leukemia - a Europe Against Cancer program.

Authors:  J Gabert; E Beillard; V H J van der Velden; W Bi; D Grimwade; N Pallisgaard; G Barbany; G Cazzaniga; J M Cayuela; H Cavé; F Pane; J L E Aerts; D De Micheli; X Thirion; V Pradel; M González; S Viehmann; M Malec; G Saglio; J J M van Dongen
Journal:  Leukemia       Date:  2003-12       Impact factor: 11.528

7.  BCR-ABL1 lymphoblastic leukaemia is characterized by the deletion of Ikaros.

Authors:  Charles G Mullighan; Christopher B Miller; Ina Radtke; Letha A Phillips; James Dalton; Jing Ma; Deborah White; Timothy P Hughes; Michelle M Le Beau; Ching-Hon Pui; Mary V Relling; Sheila A Shurtleff; James R Downing
Journal:  Nature       Date:  2008-04-13       Impact factor: 49.962

8.  Deletion of IKZF1 and prognosis in acute lymphoblastic leukemia.

Authors:  Charles G Mullighan; Xiaoping Su; Jinghui Zhang; Ina Radtke; Letha A A Phillips; Christopher B Miller; Jing Ma; Wei Liu; Cheng Cheng; Brenda A Schulman; Richard C Harvey; I-Ming Chen; Robert J Clifford; William L Carroll; Gregory Reaman; W Paul Bowman; Meenakshi Devidas; Daniela S Gerhard; Wenjian Yang; Mary V Relling; Sheila A Shurtleff; Dario Campana; Michael J Borowitz; Ching-Hon Pui; Malcolm Smith; Stephen P Hunger; Cheryl L Willman; James R Downing
Journal:  N Engl J Med       Date:  2009-01-07       Impact factor: 91.245

9.  Modeling first-hit functions of the t(12;21) TEL-AML1 translocation in mice.

Authors:  Shinobu Tsuzuki; Masao Seto; Mel Greaves; Tariq Enver
Journal:  Proc Natl Acad Sci U S A       Date:  2004-05-20       Impact factor: 11.205

10.  Identification of preleukemic precursors of hyperdiploid acute lymphoblastic leukemia in cord blood.

Authors:  Ana Teresa Maia; Roxane Tussiwand; Giovanni Cazzaniga; Paolo Rebulla; Susan Colman; Andrea Biondi; Mel Greaves
Journal:  Genes Chromosomes Cancer       Date:  2004-05       Impact factor: 5.006

View more
  43 in total

Review 1.  Somatic mosaicism: on the road to cancer.

Authors:  Luis C Fernández; Miguel Torres; Francisco X Real
Journal:  Nat Rev Cancer       Date:  2015-12-18       Impact factor: 60.716

Review 2.  Leukaemia 'firsts' in cancer research and treatment.

Authors:  Mel Greaves
Journal:  Nat Rev Cancer       Date:  2016-03       Impact factor: 60.716

3.  Murine B-1 B cell progenitors initiate B-acute lymphoblastic leukemia with features of high-risk disease.

Authors:  Encarnacion Montecino-Rodriguez; Katy Li; Michael Fice; Kenneth Dorshkind
Journal:  J Immunol       Date:  2014-04-21       Impact factor: 5.422

4.  Genetic and epigenetic analysis of monozygotic twins discordant for testicular cancer.

Authors:  Christian P Kratz; Daniel C Edelman; Yonghong Wang; Paul S Meltzer; Mark H Greene
Journal:  Int J Mol Epidemiol Genet       Date:  2014-10-22

5.  Is cancer latency an outdated concept? Lessons from chronic myeloid leukemia.

Authors:  Manuel Abecasis; Nicholas C P Cross; Manuel Brito; Isabelina Ferreira; Kathleen M Sakamoto; Nobuko Hijiya; Joannah Score; Robert Peter Gale
Journal:  Leukemia       Date:  2020-07-06       Impact factor: 11.528

Review 6.  Redefining ALL classification: toward detecting high-risk ALL and implementing precision medicine.

Authors:  Stephen P Hunger; Charles G Mullighan
Journal:  Blood       Date:  2015-05-21       Impact factor: 22.113

7.  Ikaros transcripts Ik6/10 and levels of full-length transcript are critical for chronic myeloid leukaemia blast crisis transformation.

Authors:  L Wang; A Howarth; R E Clark
Journal:  Leukemia       Date:  2014-03-12       Impact factor: 11.528

8.  Loss of Pax5 Exploits Sca1-BCR-ABLp190 Susceptibility to Confer the Metabolic Shift Essential for pB-ALL.

Authors:  Alberto Martín-Lorenzo; Franziska Auer; Lai N Chan; Idoia García-Ramírez; Inés González-Herrero; Guillermo Rodríguez-Hernández; Christoph Bartenhagen; Martin Dugas; Michael Gombert; Sebastian Ginzel; Oscar Blanco; Alberto Orfao; Diego Alonso-López; Javier De Las Rivas; Maria B García-Cenador; Francisco J García-Criado; Markus Müschen; Isidro Sánchez-García; Arndt Borkhardt; Carolina Vicente-Dueñas; Julia Hauer
Journal:  Cancer Res       Date:  2018-02-28       Impact factor: 12.701

9.  Breakpoint-specific multiplex polymerase chain reaction allows the detection of IKZF1 intragenic deletions and minimal residual disease monitoring in B-cell precursor acute lymphoblastic leukemia.

Authors:  Aurélie Caye; Kheïra Beldjord; Kelly Mass-Malo; Séverine Drunat; Jean Soulier; Virginie Gandemer; André Baruchel; Yves Bertrand; Hélène Cavé; Emmanuelle Clappier
Journal:  Haematologica       Date:  2012-10-12       Impact factor: 9.941

10.  Function of Ikaros as a tumor suppressor in B cell acute lymphoblastic leukemia.

Authors:  Philippe Kastner; Arnaud Dupuis; Marie-Pierre Gaub; Raoul Herbrecht; Patrick Lutz; Susan Chan
Journal:  Am J Blood Res       Date:  2013-01-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.